Broad- versus narrow-spectrum oral antibiotic transition and outcomes in health care-associated pneumonia

Annals of the American Thoracic Society

Volumn 14, Issue 2, 2017, Pages 200-205

  Buckel, Whitney R ^a   Stenehjem, Edward ^b,c   Sorensen, Jeff ^d   Dean, Nathan ^d   Webb, Brandon ^b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic stewardship; Bacterial antibiotic resistance; Pneumonia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFTAROLINE; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; CLINICAL OUTCOME; COMMUNITY ACQUIRED PNEUMONIA; DATA BASE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SECONDARY ANALYSIS; TREATMENT DURATION; UTAH; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; EPIDEMIOLOGY; FACTUAL DATABASE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; ORAL DRUG ADMINISTRATION; PNEUMONIA; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DATABASES, FACTUAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT READMISSION; PNEUMONIA; UTAH;

EID: 85014769232     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201606-486BC     Document Type: Article

References (27)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010. Clin Infect Dis 2015;61:1403-1410.
3. Dean NC, Jones BE, Jones JP, Ferraro JP, Post HB, Aronsky D, Vines CG, Allen TL, Haug PJ. Impact of an electronic clinical decision support tool for emergency department patients with pneumonia. Ann Emerg Med 2015;66:511-520.
4. Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, Siu AL. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med 2002;162:1278-1284.
5. Hougham GW, Ham SA, Ruhnke GW, Schulwolf E, Auerbach AD, Schnipper JL, Kaboli PJ, Wetterneck TB, Gonzalez D, Arora VM, et al. Sequence patterns in the resolution of clinical instabilities in community-acquired pneumonia and association with outcomes. J Gen Intern Med 2014;29:563-571.
6. Jones BE, Jones J, Bewick T, LimWS, Aronsky D, Brown SM, BoersmaWG, van der Eerden MM, Dean NC. CURB-65 pneumonia severity assessment adapted for electronic decision support. Chest 2011; 140:156-163.
7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, et al.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-S72.
8. Athanassa Z, Makris G, Dimopoulos G, Falagas ME. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs 2008;68:2469-2481.
9. Oosterheert JJ, Bonten MJ, Schneider MM, Buskens E, Lammers JW, Hustinx WM, Kramer MH, Prins JM, Slee PH, Kaasjager K, et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006;333:1193.
10. Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med 2001;161:722-727.
11. Aliberti S, Amir A, Peyrani P, Mirsaeidi M, Allen M, Moffett BK, Myers J, Shaib F, Cirino M, Bordon J, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 2008;134:955-962.
12. Hoogewerf M, Oosterheert JJ, Hak E, Hoepelman IM, Bonten MJ. Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia. Clin Microbiol Infect 2006;12: 1097-1104.
13. Mené ndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, et al.; Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004;59:960-965.
14. Blasi F, Ostermann H, Racketa J, Medina J, McBride K, Garau J; REACH Study Group. Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study. Respir Res 2014;15:6.
15. Garau J, Baquero F, Pé rez-Trallero E, Pé rez JL, Martín-Sá nchez AM, García-Rey C, Martín-Herrero JE, Dal-Ré R; NACER Group. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008;14:322-329.
16. Labelle AJ, Arnold H, Reichley RM, Micek ST, Kollef MH. A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 2010;137:1130-1137.
17. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al.; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373:415-427.
18. Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013;67:11-18.
19. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, Imaizumi K, Sato T, Hasegawa Y. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009;135:633-640.
20. Gadsby NJ, Russell CD, McHugh MP, Mark H, Conway Morris A, Laurenson IF, Hill AT, Templeton KE. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016;62:817-823.
21. Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med 2014;2:238-246.
22. Yamasaki K, Kawanami T, Yatera K, Fukuda K, Noguchi S, Nagata S, Nishida C, Kido T, Ishimoto H, Taniguchi H, et al. Significance of anaerobes and oral bacteria in community-acquired pneumonia. PLoS One 2013;8:e63103.
23. Webb BJ, Jones B, Dean NC. Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia. Curr Opin Infect Dis 2016;29:167-177.
24. Schlueter M, James C, Dominguez A, Tsu L, Seymann G. Practice patterns for antibiotic de-escalation in culture-negative healthcareassociated pneumonia. Infection 2010;38:357-362.
25. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y. Implication of clinical pathway care for communityacquired pneumonia in a community hospital: early switch from an intravenous b-lactam plus a macrolide to an oral respiratory fluoroquinolone. Intern Med 2008;47:1865-1874.
26. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, et al.; American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-1754.
27. Engel MF, Postma DF, Hulscher ME, Teding van Berkhout F, Emmelot-Vonk MH, Sankatsing S, Gaillard CA, Bruns AH, Hoepelman AI, Oosterheert JJ. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J 2013;41:123-130.